Differential nuclear matrix protein expression in prostate cancers: Correlation with pathologic stage

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1354-1358

  Lakshmanan, Yegappan ^a   Subong, Eric N P ^a   Partin, Alan W ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Electrophoresis; Nuclear matrix proteins; Prostate cancer; Staging

Indexed keywords

NUCLEAR PROTEIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN INDUCTION; SILVER STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0031897088     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63615-2     Document Type: Article

References (35)

1. Berezney, R. and Coffey, D. S.: Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun., 60: 1410, 1974.
2. Fey, E. G., Bangs, P., Sparks, C. and Odgren, P.: The nuclear matrix: defining structural and functional roles. Crit. Rev. Eukaryotic Gene Expression, 1: 127, 1991.
3. Getzenberg, R. H., Pienta, K. J., Ward, W. S. and Coffey, D. S.: Nuclear structure and the three-dimensional organization of DNA. J. Cell. Biochem., 47: 289, 1991.
4. Stuurman, N., Meijne, A. M. L., Van der Pol, A. J., de Jong, L., Van Driel, R. and Van Renswoude, J.: The nuclear matrix from cells of different origin: evidence for a common set of matrix proteins. J. Biol. Chem., 265: 5460, 1990.
5. Gerace, L., Comeau, C. and Benson, M.: Organization and modulation of the nuclear lamina structure. J. Cell Sci. (Suppl.), 1: 137, 1984.
6. Lydersen, B. K. and Pettijohn, D. E.: Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell. Cell, 22: 489, 1980.
7. Berrios, M., Osheroff, N. and Fisher, P. A.: In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc. Natl. Acad. Sci. USA, 82: 4142, 1985.
8. Fey, E. G. and Penman, S.: Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl. Acad. Sci. USA, 85: 121, 1988.
9. Getzenberg, R. H. and Coffey, D. S.: Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol. Endocrinol., 4: 1336, 1990.
10. Getzenberg, R. H., Pienta, K. J., Huang, Y. W. and Coffey, D. S.: Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res., 51: 6514, 1991.
11. Getzenberg, R. H., Konety, B. R., Oeler, T. A., Quigley, M. M., Hakam, A., Becich, M. J. and Bahnson, R. R.: Bladder cancer-associated nuclear matrix proteins. Cancer Res., 56: 1690, 1996.
12. Khanuja, P. S., Lehr, J. E., Soule, H. D., Gehani, S. K., Noto, A. C., Choudhury, S., Chen, R. and Pienta, K. J.: Nuclear matrix proteins in normal and breast cancer cells. Cancer Res., 53: 3394, 1993.
13. Keesee, S. K., Meneghini, M. D., Szaro, R. P. and Wu, Y. J.: Nuclear matrix proteins in human colon cancer. Proc. Natl. Acad. Sci. USA, 91: 1913, 1994.
14. Pienta, K. J. and Lehr, J. E.: A common set of nuclear matrix proteins in prostate cancer cells. Prostate, 23: 61, 1993.
15. Keesee, S. K., Briggman, J. V., Thill, G. and Wu, Y. J.: Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryotic Gene Expression, 6: 189, 1996.
16. Replogle-Schwab, R., Pienta, K. J. and Getzenberg, R. H.: The utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryotic Gene Expression, 6: 103, 1996.
17. Partin, A. W., Getzenberg, R. H., Carmichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I. and Coffey, D. S.: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744, 1993.
18. Nelson, W. G., Pienta, K. J., Barrack, E. R. and Coffey, D. S.: The role of the nuclear matrix in the organization and function of DNA. Ann. Rev. Biophys. Biophys. Chem., 15: 457, 1986.
19. Pardoll, D. M., Vogelstein, B. and Coffey, D. S.: A fixed site of DNA replication in eukaryotic cells. Cell, 19: 527, 1980.
20. Berezney, R. and Coffey, D. S.: Nuclear protein matrix: association with newly synthesized DNA. Science, 189: 291, 1975.
21. Getzenberg, R. H., Pienta, K. J. and Coffey, D. S.: The tissue matrix: cell dynamics and hormone action. Endocrine Rev., 11: 399, 1990.
22. Pienta, K. J., Partin, A. W. and Coffey, D. S.: Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res., 49: 2525, 1989.
23. Shaper, J. H., Pardoll, D. M., Kaufmann, S. H., Barrack, E. R., Vogelstein, B. and Coffey, D. S.: The relationship of the nuclear matrix to cellular structure and function. Adv. Enz. Reg., 17: 213, 1979.
24. Bidwell, J. P., Fey, E. G., Van Wijnen, A. J., Penman, S., Stein, J. L., Lian, J. B. and Stein, G. S.: Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res., 54: 28, 1994.
25. Patton, W. F., Pluskal, M. G., Skea, W. M., Buecker, J. L., Lopez, M. F., Zimmerman, R., Belanger, L. M. and Hatch, P. D.: Development of a dedicated two-dimensional gel electrophoresis system that provides optimal pattern reproducibility and polypeptide resolution. BioTechniques, 8: 518, 1990.
26. Wray, W., Boulikas, T., Wray, V. and Hancock, R.: Silver staining or proteins in polyacrylamide gels. Anal. Biochem., 118: 197, 1981.
27. Partin, A. W., Pound, C. R., Clemens, J., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol. Clin. North Am., 20: 713, 1993.
28. Scardino, P. T.: Early detection of prostate cancer. Urol. Clin. North Am., 16: 635, 1989.
29. Carter, H. B., Piantadosi, S. and Isaacs, J. T.: Clinical evidence for and implications of the multistep development of prostate cancer. J. Urol., 143: 742, 1990.
30. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
31. Partin, A. W., Subong, E. N. P., Walsh, P. C., Wojno, K. J., Oesterling, J. E., Kattan, M. W., Scardino, P. T. and Pearson, J. D.: Combination of prostate-specific antigen, clinical stage and gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. J.A.M.A., 277: 1445, 1997.
32. Bauer, J. J., Connelly, R. R., Sesterhenn, I. A., Bettencourt, M., McLeod, D. G., Srivastava, S. and Moul, J. W.: Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy. Cancer, 79: 952, 1997.
33. Lange, P. H. and Narayan, P.: Understaging and undergrading of prostate cancer. Urology, 21: 113, 1983.
34. Epstein, J. I. and Steinberg, G. D.: The significance of low-grade prostate cancer on needle biopsy. Cancer, 66: 1927, 1990.
35. Mohler, J. L., Partin, A. W., Epstein, J. I., Lohr, W. D. and Coffey, D. S.: Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. J. Urol., 139: 1085, 1988.